Pathogenetic aspects of the use of metabiotics


Дәйексөз келтіру

Толық мәтін

Ашық рұқсат Ашық рұқсат
Рұқсат жабық Рұқсат берілді
Рұқсат жабық Рұқсат ақылы немесе тек жазылушылар үшін

Аннотация

The article discusses the role of human microbiocenosis in life activity. Microbiocenosis has an effect on the human body not only quantitatively, but also as an important regulatory organ that interacts with a macroorganism, from direct intercellular interactions to a whole system of signaling molecules that affect the functions of various organs and organ systems, including the central nervous system. One of the significant areas of therapeutic measures aimed at correcting disorders of microbiocenosis is the use of probiotic drugs with different levels of action.

Толық мәтін

Рұқсат жабық

Авторлар туралы

A. Ploskireva

Central Research Institute of Epidemiology; Pirogov Russian National Research Medical University

Email: antonina@ploskireva.com

Әдебиет тізімі

  1. Mechnikoff E. The prolongation of life: optimistic studies. New York & London - G.P Putnam's, Sons. 1908.
  2. Мечников И.И. Этюды оптимизма. М., 1988. 328 с.
  3. Montiel-Castro A.J., Gonzalez-Cervantes R.M., Bravo-Ruiseco G, Pacheco-Ldpez G. The microbiota-gut-brain axis: neurobehavioral correlates, health and sociality. Front Integr Neurosci. 2013;7:70. Doi: 10.3389/ fnint.2013.00070.
  4. Бондаренко В.М., Рябиченко Е.В. Кишечномозговая ось. Нейронные и иммуновоспали-тельные механизмы патологии мозга и кишечника. Журнал микробиологии. 2013;2:112- 20.
  5. Шендеров Б.А., Голубев В.Л., Данилов А.Б., Прищепа А.В. Кишечная микробиота человека и нейродегенеративные заболевания. Поликлиника. 2016;1:7-13
  6. Machado M.V, Cortez-Pinto H. Diet, Microbiota, Obesity, and NAFLD: A Dangerous Quartet. Int J Mol Sci. 2016;17(4):pii: E481. Doi: 10.3390/ ijms17040481.
  7. Thushara R.M., Gangadaran S., Solati Z, Moghadasian M.H. Cardiovascular benefits of probiotics: a review of experimental and clinical studies. Food Funct. 2016;7(2):632-42. doi: 10.1039/c5fo01190f.
  8. Stilling R.M., Dinan T.G., Cryan J.F. Microbial genes, brain & behaviour - epigenetic regulation of the gut-brain axis. Genes Brain Behav. 2014;13:69-86. doi: 10.1111/gbb.12109.
  9. Li J., Jia H, Cai X, et al. An integrated catalog of reference genes in the human gut microbiome. Nat Biotechnol. 2014;32:834-41. Doi: 10.1038/ nbt.2942.
  10. Forsythe P, Kunze W.A. Voices from within: gut microbes and the CNS. Cell Mol Life Sci. 2013;70:55-69.
  11. Олескин А.В., Эль-Регистан Г.И., Шендеров Б.А. Межмикробные химические взаимодействия и диалог микробиота-хозяин: роль нейромедиаторов. Микробиология. 2016;85(1):1-24.
  12. Всемирная гастроэнтерологическая ассоциация. Практические рекомендации. Пробиотики и пребиотики. Май 2008. URL: http://www. worldgastroenterology.org/assets/downloads/ru/ pdf/guidelines/19_probiotics_prebiotics_ru.pdf. [World Gastroenterological Association. Practicalrecommendations. Probiotics and prebiotics. May 2008. URL: http://www.worldgastroenterology. org/assets/downloads/en/pdf/guidelines/19_ probiotics_prebiotics_en.pdf. (In Russ.)].
  13. Бондаренко В.М. Обоснование и тактика назначения в медицинской практике различных форм пробиотических препаратов. Фарматека. 2012;13:77-87
  14. Shenderov В.А. Metabiotics: novel idea or natural development of probiotic conception. Microbial Ecol Health Dis. 2013;24:20399. Doi: http:// dx.doi.org/10.3402/mehd.v24i0.20399.
  15. Sugahara H, Odamaki T., Hashikura N., et al. Differences in folate production by bifidobacteria of different origins. Biosci Microbiota Food Health. 2015;34:87-93. doi: 10.12938/bmfh.2015-003.
  16. Marley M.G., Meganathan R., Bentley R. Menaquinone (vitamin К2) biosynthesis in escherichia coli: Synthesis of o-succinylbenzoate does not require the decarboxylase activity of the ketoglutarate dehydrogenase complex. Biochemistry. 1986;25:1304-307. Doi: 10.1021/ bi00354a017.
  17. Flint H.J., Bayer E.A., Rincon M.T., et al. Polysaccharide utilization by gut bacteria: Potential for new insights from genomic analysis. Nat Rev Microbiol. 2008;6:121-31. Doi: 10.1038/ nrmicro1817.
  18. Le Poul E, loison C., Struyf S., et al. Functional characteristics of human short chain fatty acid receptors and their role in polymorphonuclear cell activation. J Biol Chem. 2003;278:25481-89. Doi: http://dx.doi.org/ 10.1074/jbc. M301403200. PMID: 12711604
  19. Brown A.J., Goldsworthy S.M., Barnes A.A., et al. Orphan G Proteins-coupled GP41 and GPR43 receptors are activated by propionate and other short chain carboxylic acids. J Biol Chem. 2003;278:11312-19. Doi: http:// dx.doi.org/10.1074/jbc. M211609200. PMID: 12496283.
  20. Nilsson N.E., Oman C., Olde B. Identification of the free fatty acid receptor, FFA 2R, is expressed on leukocytes and activated by short-chain fatty acids. Biochem Biophys Res Commun. 2003;303:1047-52. Doi: http://dx.doi.org/10.1016/S0006-291X(03)00488-1. PMID: 12684041.
  21. Mischke M., Plsch T. The Gut Microbiota and their Metabolites: Potential Implications for the Host Epigenome. Adv Exp Med Biol. 2016;902:33-44. doi: 10.1007/978-3-319-31248-4_3.
  22. Van der Beek C.M., Bloemen J.G., van den Broek M.A., et al. Hepatic Uptake of Rectally Administered Butyrate Prevents an Increase in Systemic Butyrate Concentrations in Humans. J Nutr. 2015;145(9):2019-24.
  23. Donohoe D.R., Collins L.B., Wali A., et al. The Warburg effect dictates the mechanism of butyrate-mediated histone acetylation and cell proliferation. Mol Cell. 2012;48:612-26. Doi: http://dx.doi. org/10.1016/j.molcel.2012.08.033. PMID: 23063526.
  24. Головенко О.В., Халиф И.Л., Головенко А.О. Роль масляной кислоты в лечении органических и функциональных заболеваний толстой кишки. Клинические перспективы гастроэнтерологии, гепатологии. 2001;3:20-9.
  25. Cani P.D., Bibiloni R., Knauf C., et al. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes. 2008;57:1470-81. Doi: http://dx.doi.org/10.2337/db07-1403. PMID: 18305141.
  26. Ардатская М.Д. Клиническое значение короткоцепочечных жирных кислот при патологии желудочно-кишечного тракта. Дисс. докт. мед. наук. М., 2003.
  27. Shenderov B.A. Probiotic (symbiotic) bacterial languages. Anaerobe. 2011;17(6):490-95. doi: 10.1016/j.anaerobe.2011.05.009.
  28. Hrusovska F, Blanarikova Z., Ondrisova M., Michalickova J. Hylak Forte drops in the treatment of atopic eczema in children. Cesk Pediatr. 1993;48(2):94-6. PMID: 8477481.
  29. Rudkowski Z., Bromirska J. Reduction of the duration of salmonella excretion in infants with Hylak forte. Padiatr Padol. 1991;26(2):111-14. PMID: 1945464.
  30. Florkiewicz H., Szurska G. Role of the hylak forte preparation in the prevention of dysbacteriosis following intraoral antibiotic therapy. Pol Tyg Lek. 1963;18:1066-68. PMID: 14074756.
  31. Patil S., Sawant S., Hauff K., Hampp G. Validated Postbiotic Screening Confirms Presence of Physiologically-Active Metabolites, Such as Short-Chain Fatty Acids, Amino Acids and Vitamins in Hylak® Forte. Probiotics Antimicrob. Proteins. 2018. doi: 10.1007/s12602-018-9497-5. PMID: 30560425.

Қосымша файлдар

Қосымша файлдар
Әрекет
1. JATS XML
Жүктеу

Осы сайт cookie-файлдарды пайдаланады

Біздің сайтты пайдалануды жалғастыра отырып, сіз сайттың дұрыс жұмыс істеуін қамтамасыз ететін cookie файлдарын өңдеуге келісім бересіз.< / br>< / br>cookie файлдары туралы< / a>